数字行为疗法改善中轴型脊柱关节炎持续疼痛患者结局:随机对照试验
这项非盲、多中心随机对照试验纳入136例中轴型脊柱关节炎持续疼痛患者,比较接受接纳承诺疗法(ACT)应用程序的干预组与标准治疗组,12周后干预组疼痛相关生活干扰和疾病相关情感困扰的改善大于标准治疗组,但置信区间均包含0。
要点
- ACT应用程序组疼痛相关生活干扰改善大于标准治疗组(β -0.36,95%CI -0.73至0.01)。
- ACT应用程序组疾病相关情感困扰改善大于标准治疗组(β -0.4,95%CI -0.84至0.03)。
- 干预组73例中44例主动使用ACT应用程序,19例(43%)完成全部课程。
核心结论
- ACT应用程序在疼痛相关生活干扰方面表现出有意义的减少,支持数字健康应用可能成为中轴型脊柱关节炎患者疼痛管理的补充工具。
研究设计与样本
- 非盲、多中心随机对照试验,纳入136例中轴型脊柱关节炎持续疼痛患者,随机分为干预组(n=73,接受ACT应用程序)和标准治疗组(n=63,不接受ACT应用程序)。
主要发现
- 干预组疼痛相关生活干扰改善大于标准治疗组(β -0.36,95%CI -0.73至0.01)。
- 干预组疾病相关情感困扰改善大于标准治疗组(β -0.4,95%CI -0.84至0.03)。
- 干预组73例中44例主动使用ACT应用程序,19例(43%)完成全部课程。
关键数值与推荐
- 主要结局为MPI疼痛相关生活干扰,次要结局包括疼痛严重程度、情感困扰及其他患者报告结局,评估时间点为12周。
临床怎么用
- ACT应用程序可能作为中轴型脊柱关节炎持续疼痛患者的补充疼痛管理工具。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Axial spondyloarthritis (axSpA) is often associated with persistent pain despite effective anti-inflammatory treatment. Digital health applications (DHAs) provide innovative approaches to address multidimensional aspects of persistent pain through psychological and behavioral strategies. The aim of this study was to assess the impact of a DHA using acceptance and commitment therapy (ACT) on disease outcomes, including the West Haven-Yale Multidimensional Pain Inventory (MPI), in patients with axSpA experiencing persistent pain despite stable pharmacological therapy. METHODS: This unblinded, multicentric, randomized controlled trial compared an intervention group (IG) receiving the ACT app with a standard of care (SOC) group. The ACT app provided behavioral therapy. The primary outcome was MPI pain-related life interference; secondary outcomes included pain severity, affective distress, and other patient-reported outcomes after 12 weeks. Linear models estimating the effect of the ACT app on the change of MPI pain-related life interference and affective distress were calculated. RESULTS: A total of 136 patients were randomized to IG (n = 73) with the ACT app and SOC (n = 63) without the ACT app. In the IG, 44 actively used the ACT app. All lessons in the ACT app were completed by 19 IG patients (43%). Baseline characteristics, including MPI scores, were comparable between groups. IG showed a reduction in pain-related life interference as well as in other outcomes. The improvements in pain-related life interference (β with -0.36, 95% confidence interval [CI]: -0.73 to 0.01) and affective distress related to the disease (-0.4; 95% CI -0.84 to 0.03) were greater compared with SOC. CONCLUSION: The ACT app demonstrated a meaningful reduction in pain-related life interference, supporting that DHAs might become a complementary tool in managing pain for patients with axSpA. Studies about improving adherence to DHAs are warranted.
引用
- Kiefer D, Sonkaya Y, Krause D, et al. Digital Behavioral Therapy Improves Outcome in Patients With Axial Spondyloarthritis and Persistent Pain: A Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2025. PMID: 41120227. doi:10.1002/acr.25679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。